Interim analysis of a phase I dose escalation trial of the antibody drug conjugate (ADC) AGS15E (ASG-15ME) in patients (Pts) with metastatic urothelial cancer (mUC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Petrylak, D
  • Heath, E
  • Sonpavde, G
  • George, S
  • Morgans, AK
  • Eigl, BJ
  • Picus, J
  • Cheng, S
  • Hotte, Sebastien
  • Gartner, E
  • Vincent, M
  • Chu, R
  • Anand, B
  • Morrison, Katherine
  • Jackson, L
  • Melhem-Bertrandt, A
  • Yu, EY

publication date

  • October 1, 2016